Carbapenemase Transmission in CREC in Guangdong

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) is an important component of the broader carbapenem-resistant Enterobacteriaceae (CRE) problem. In China, CREC is reported among the more frequently detected CRE species, and its clinical significance is amplified by the ability of carbapenemase-encoding genes (CEGs) to move between bacterial cells. These genes can be carried on plasmids, retained on chromosomes, or associated with mobile genetic elements that facilitate persistence and dissemination.

The reference study by Chen et al. in BMC Microbiology addresses a gap in surveillance: many investigations report whether a CREC isolate is resistant, but fewer simultaneously determine where a carbapenemase gene is located, whether it can transfer by conjugation, which mobile elements accompany it, and how isolates are related by molecular typing. The authors analyzed 54 CREC strains collected from eight teaching hospitals in Guangdong province between December 2022 and June 2024.

The research question was therefore not limited to prevalence. It asked how CEGs were distributed between plasmids and chromosomes, how efficiently they could disseminate horizontally, whether resistant isolates shared clonal patterns across hospitals and departments, and which patient or specimen categories were most frequently represented. The COVID-19 pandemic provides important context because increased antibiotic exposure, disrupted healthcare services, and complex infections may intensify selection and transmission; however, the study primarily characterizes the sampled population rather than proving a pandemic-specific causal effect.

Key Innovation from the Reference Study

The main innovation is the integration of four evidence layers into one CREC investigation. First, PCR and variable-temperature sodium dodecyl sulfate (SDS) plasmid elimination were used to infer the cellular location of CEGs. Second, broth microdilution connected CEG status with antimicrobial susceptibility. Third, plasmid conjugation tested whether resistance determinants were transferable rather than merely present. Finally, mobile genetic element analysis and ERIC-PCR with NTSYS software provided complementary information about genetic context and strain relatedness.

This design distinguishes gene presence from gene mobility. A carbapenemase gene detected by PCR is epidemiologically important, but a plasmid-borne gene that transfers efficiently to a recipient strain represents a different level of transmission risk. The study also avoids treating all CREC as one homogeneous population: it examines resistance determinants, genetic backgrounds, and hospital distribution together.

Another useful feature is the comparison of CEG-positive and CEG-negative isolates. This allows the investigators to evaluate whether carrying a detected carbapenemase gene corresponds to a broader resistance phenotype, rather than assuming that carbapenem resistance has the same molecular basis in every isolate.

Methods and Experimental Design Insights

The experimental workflow was structured as a sequence of phenotypic, molecular, mobility, and epidemiological analyses. Because the article is an observational laboratory investigation, its procedures should be interpreted as study parameters rather than as a universal clinical or diagnostic protocol.

Protocol Parameters

• Sampling frame: 54 CREC isolates collected from eight teaching hospitals in Guangdong province from December 2022 through June 2024.
• CEG detection and localization: PCR was combined with variable-temperature SDS plasmid elimination to assess whether detected genes were associated with plasmids, chromosomes, or both.
• Susceptibility testing: Broth microdilution was used to compare resistance patterns in CEG-positive and CEG-negative groups, including imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin.
• Conjugation assessment: Plasmid conjugation experiments followed by PCR evaluated transfer of the detected bla_NDM-1, bla_IMP, and bla_KPC-2 genes.
• Mobile-element profiling: Six classes of mobile genetic elements were examined, with ISEcp1 identified as the most frequently detected element in the study population.
• Strain relatedness: ERIC-PCR fingerprints were analyzed using NTSYS software to classify isolates into genotypes and assess patterns spanning departments and hospitals.

This combination offers practical methodological lessons for antibiotic resistance research. Plasmid curing alone does not establish a complete genetic map, and conjugation results depend on the donor, recipient, selection conditions, and compatibility of the transferable element. Nevertheless, using localization, transfer, and fingerprinting assays in parallel provides stronger epidemiological inference than relying on any one test.

Core Findings and Why They Matter

CEGs were detected in 46 of 54 isolates, corresponding to 85.19% of the CREC collection, according to the reference study. The distribution strongly favored bla_NDM-1. Eighteen isolates, or 33.33% of the total collection, carried bla_NDM-1 on both chromosomes and plasmids. A further 25 isolates, or 46.30%, carried bla_NDM-1 exclusively on plasmids. Two isolates contained only plasmid-associated bla_IMP, while one isolate carried both plasmid-associated bla_NDM-1 and bla_KPC-2. These categories account for the 46 CEG-positive strains reported by the authors.

The predominance of plasmid-associated bla_NDM-1 is particularly important. Plasmid carriage creates a route for horizontal gene transfer that is independent of bacterial clonal expansion. At the same time, detection on both plasmids and chromosomes suggests that the same resistance determinant may be maintained through more than one genetic reservoir. This can complicate decolonization of resistance within a hospital population and makes gene-level surveillance more informative than species-level reporting alone.

Conjugation results supported the mobility concern. CEG transfer was successful for 44 of 46 positive isolates, or 95.65%, in the reported experiments. The transfer success rates were 42 of 44 for bla_NDM-1, 2 of 2 for bla_IMP, and 0 of 1 for bla_KPC-2. The denominators differ because they reflect the gene-bearing isolates tested in each category. The result does not mean that every clinical encounter will produce transfer; it shows that the tested genetic backgrounds had substantial transfer potential under the experimental conditions.

CEG-positive isolates also showed significantly higher resistance rates than the CEG-negative group for imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin, with significance reported at P<0.05. This association supports the view that carbapenemase carriage is part of a multidrug-resistance phenotype, although it does not establish that the carbapenemase gene alone caused resistance to every listed drug. Additional mechanisms, including porin changes, efflux, target alterations, or unrelated resistance genes, may contribute.

The mobile-element results add another layer. ISEcp1 was detected in 47 of 54 isolates, or 87.04%, making it the most prevalent of the six analyzed mobile-element types. Isolates carrying four mobile-element types simultaneously were the largest subgroup, comprising 22 of 54 strains, or 40.74%. These observations are consistent with a highly plastic resistance environment in which plasmid architecture and insertion sequences may support the capture, maintenance, or rearrangement of resistance determinants.

ERIC-PCR and NTSYS analysis divided the 54 isolates into 17 genotypes. Types E and G were each represented by 11 isolates, or 20.37% of the collection, and originated from different departments in five hospitals. Two type E isolates had a Dice similarity coefficient of 100%. This pattern suggests both interdepartmental and interhospital distribution, but it should not be interpreted as definitive proof of direct transmission without patient movement data, sampling dates, whole-genome sequencing, and environmental or healthcare-worker sampling.

The clinical distribution was also uneven. Men accounted for 35 isolates, or 64.81%; elderly patients accounted for 39, or 72.22%; respiratory medicine contributed 11, or 20.37%; and sputum samples contributed 18, or 33.33%. These values identify where surveillance yielded the most detections, not necessarily independent risk factors. The findings nevertheless support targeted attention to respiratory-care pathways, older patient populations, and sputum-derived CREC collections.

Comparison with Existing Internal Articles

The internal article Transmission Dynamics of Carbapenemase Genes in CREC in Guangdong provides a concise overview of the same study and emphasizes the prevalence and mobility of plasmid-mediated bla_NDM-1. It is useful as an entry point, whereas the present analysis places greater emphasis on why combining localization, conjugation, mobile-element profiling, and strain typing changes the interpretation of transmission.

A second related resource, Multidrug Resistance Dynamics in CREC: Insights from Guangdong Hospitals, foregrounds the multidrug-resistance phenotype and infection-control implications. Chen et al.'s study supports that perspective but adds a mechanistic bridge: CEG-positive status is associated with broader resistance, and the dominant bla_NDM-1 determinant is frequently plasmid-associated and transferable. The two perspectives are complementary rather than redundant—one stresses phenotype and surveillance, while the other clarifies genetic location and dissemination potential.

Limitations and Transferability

The sample size was modest, with 54 isolates from eight teaching hospitals, so prevalence estimates should not be generalized automatically to all hospitals in Guangdong, China, or other regions. The collection may also reflect local referral patterns, department-specific sampling, and the availability of isolates rather than population-wide incidence.

The study used PCR, plasmid elimination, conjugation, mobile-element detection, and ERIC-PCR. These methods are informative but provide less resolution than complete plasmid sequencing and whole-genome sequencing. In particular, plasmid curing can alter bacterial physiology, PCR does not fully define gene neighborhoods, and ERIC-PCR similarity does not prove direct transmission. The high conjugation success rate is therefore evidence of experimental transferability, not a direct estimate of transmission probability in patients.

Interpretation of the pandemic context also requires caution. The study period followed the early phase of COVID-19, but there was no controlled pre-pandemic comparison described in the condensed findings. Consequently, the data support strengthened surveillance during periods of healthcare disruption and high antibiotic use, while not quantifying the independent effect of COVID-19. Finally, the study reports associations between CEG status and resistance, not treatment outcomes or prospective clinical effectiveness.

Research Support Resources

For laboratory susceptibility benchmarking and controlled antibiotic resistance research, researchers can use Ertapenem (sodium salt) (SKU C3451). Ertapenem sodium salt is a broad-spectrum carbapenem antibiotic and an antibacterial agent for Gram-positive and Gram-negative bacteria; it may be used as a comparator in assays examining carbapenem exposure, cell-wall inhibition, or resistance phenotypes. Such experiments should be distinguished from clinical treatment of bacterial infections, and the pharmacokinetics of ertapenem should be considered separately from in vitro concentration-response designs. The reagent is intended for scientific research use only, not diagnostic or medical purposes.